Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1981 1
1982 3
1983 2
1984 6
1985 4
1986 3
1987 1
1988 2
1989 6
1990 8
1991 7
1992 11
1993 8
1994 9
1995 8
1996 7
1997 5
1998 8
1999 16
2000 10
2001 16
2002 20
2003 28
2004 31
2005 33
2006 37
2007 29
2008 44
2009 68
2010 85
2011 72
2012 110
2013 115
2014 142
2015 143
2016 167
2017 155
2018 191
2019 198
2020 272
2021 321
2022 374
2023 336
2024 436
2025 491
2026 327

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,912 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.
Carbone DP, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Felip E, Cheng Y, Juan-Vidal O, Alexandru A, Mizutani H, Reinmuth N, Lu S, Reck M, John T, Scherpereel A, De Marchi P, Aoyama T, Sathyanarayana P, Grootendorst DJ, Hu N, Ip V, Hung YH, Paz-Ares LG. Carbone DP, et al. Among authors: hu n. ESMO Open. 2025 Jun;10(6):105123. doi: 10.1016/j.esmoop.2025.105123. Epub 2025 May 29. ESMO Open. 2025. PMID: 40446626 Free PMC article. Clinical Trial.
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.
Janjigian YY, Shitara K, Ajani JA, Shen L, Garrido M, Gallardo C, Wyrwicz L, Yamaguchi K, Cleary JM, Elimova E, Bruges R, Karamouzis M, Skoczylas T, Bragagnoli A, Liu T, Tehfe M, Zander T, Kowalyszyn R, Pazo-Cid R, Schenker M, Feeny K, McCraith S, Hu N, Lei M, Zhang J, Moehler M. Janjigian YY, et al. Among authors: hu n. Ann Oncol. 2026 Jun;37(6):787-797. doi: 10.1016/j.annonc.2026.02.003. Epub 2026 Feb 11. Ann Oncol. 2026. PMID: 41687718 Free article. Clinical Trial.
Spatially resolved single-cell atlas reveals the macroevolutionary trajectory of animal hearts.
Lian S, Wang W, Liu Y, Lu M, Han W, Luo J, Zhang X, Pang Y, Li Y, Li Y, Dang X, Wang P, Qin Y, Tan N, Zhang F, Zhang J, Gao S, Zhang R, Guo L, Jiang L, Zhang P, Zhang Y, Qu Z, Pan S, Zhang Y, Hu N, Chen Y, Cao Y, Li W, Chen X, Shi J, Yang S, Li Y, Song Q, Bao L, Li Y, Liu X, Wang J, Zhang L, Li R, Yu X, Yang T, Chen J, Li L, Zhang M, Li L, Zhang R, Li H, Gu Y, Xu X, Yang H, Bao Z, Burns CG, Burns CE, Kelly RG, Wang J, Zhao Y, Su Y, Fan G, Liu Q, Wang S, Fei JF, Pan S, Zhao L. Lian S, et al. Among authors: hu n. Science. 2026 Sep 3;393(6815):eadw0855. doi: 10.1126/science.adw0855. Epub 2026 Sep 3. Science. 2026. PMID: 42490418
Prediction of pharmacokinetics and central nervous system effects of fentanyl and alfentanil in mice, rats, and humans using a cross-species physiologically based pharmacokinetic-pharmacodynamic model and in vitro pharmacokinetic/pharmacodynamic parameters.
Shao Q, Deng Y, Gu W, Yang L, Hu N, Liu X, Liu L. Shao Q, et al. Among authors: hu n. Drug Metab Dispos. 2026 Jul;54(7):100319. doi: 10.1016/j.dmd.2026.100319. Epub 2026 May 5. Drug Metab Dispos. 2026. PMID: 42424960
3,912 results